Literature DB >> 12545297

Pregnancy in congenital cardiac disease: an increasing challenge for cardiologists and obstetricians -- a prospective multicenter study.

H Kaemmerer1, U Bauer, J-I Stein, S Lemp, D Bartmus, A Hoffmann, S Niesert, R Osmers, S Fratz, S Rossa, P E Lange, A Beitzke, K T M Schneider, J Hess.   

Abstract

OBJECTIVES: Aim of this study was to assess the occurrence of pregnancy-related complications of mother and child during pregnancy, delivery and puerperium in women with CCD prospectively. STUDY DESIGN, POPULATION: This prospective multicenter study included 122 pregnancies in 106 women with CCD (72 with, 34 without previous cardiac surgery). Patient age was 17-44, median 26 years. Cardiac and non-cardiac complications, mode of delivery, abortion, and CCD of the newborn were assessed.
RESULTS: Initially all women were in Functional Class I or II. Worsening during pregnancy occurred in 25.5% (n=27), mainly during the second and third trimester. Significant problems due to bleeding, hypertension, rhythm disturbances, endocarditis, liver congestion, increasing cyanosis or death, occurred in 11.3%. Twelve per cent of deliveries were premature. Five women had therapeutic abortion, nine spontaneous abortions, nine preterm births, and one intrauterine death. Seventy-nine per cent (n=85) delivered spontaneously; 21.3% (n=23) had caesarean section. Of the 111 live born children, 5.4% (n=6) had a CCD.
CONCLUSIONS: Most women with CCD and a good functional class before pregnancy tolerate pregnancy without major problems. However, pregnancy may induce serious cardiac and obstetric complications. The specific risks require an individualized multidisciplinary patient-management by experienced physicians.

Entities:  

Mesh:

Year:  2003        PMID: 12545297     DOI: 10.1007/s00392-003-0880-0

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  6 in total

1.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

2.  Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis.

Authors:  W Drenthen; P G Pieper; J W Roos-Hesselink; A C M Schmidt; B J M Mulder; A P J van Dijk; H W Vliegen; K M Sollie; A A Voors; T Ebels; D J van Veldhuisen
Journal:  Heart       Date:  2006-07-03       Impact factor: 5.994

3.  Contraception and Pregnancy Planning in Women With Congenital Heart Disease.

Authors:  Kathryn J Lindley; Shayna N Conner; Alison G Cahill; Tessa Madden
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

Review 4.  [Anticoagulation and thrombophilia in pregnancy].

Authors:  C Gohlke-Bärwolf; S Pildner von Steinburg; H Kaemmerer; V Regitz-Zagrosek
Journal:  Internist (Berl)       Date:  2008-07       Impact factor: 0.743

5.  Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients.

Authors:  Rhoia Clara Neidenbach; Eckart Lummert; Matthias Vigl; Reinhard Zachoval; Michael Fischereder; Andrea Engelhardt; Claudia Pujol; Renate Oberhoffer; Nicole Nagdyman; Peter Ewert; Michael Hauser; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

6.  Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases.

Authors:  Innocenzo Bianca; Giovanna Geraci; Michele Massimo Gulizia; Gabriele Egidy Assenza; Chiara Barone; Marcello Campisi; Annalisa Alaimo; Rachele Adorisio; Francesca Comoglio; Silvia Favilli; Gabriella Agnoletti; Maria Gabriella Carmina; Massimo Chessa; Berardo Sarubbi; Maurizio Mongiovì; Maria Giovanna Russo; Sebastiano Bianca; Giuseppe Canzone; Marco Bonvicini; Elsa Viora; Marco Poli
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.